Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 4156456, 8 pages
http://dx.doi.org/10.1155/2016/4156456
Research Article

A Fusion Protein Consisting of the Vaccine Adjuvant Monophosphoryl Lipid A and the Allergen Ovalbumin Boosts Allergen-Specific Th1, Th2, and Th17 Responses In Vitro

1Vice President’s Research Group 1: Molecular Allergology, Paul-Ehrlich-Institut, Langen, Hessen, Germany
2Division of Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany
3Division of Microbiology, Paul-Ehrlich-Institut, 63225 Langen, Germany

Received 7 March 2016; Revised 25 April 2016; Accepted 17 May 2016

Academic Editor: Leandro J. Carreño

Copyright © 2016 Stefan Schülke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Justicia, V. Cardona, P. Guardia et al., “Validation of the first treatment-specific questionnaire for the assessment of patient satisfaction with allergen-specific immunotherapy in allergic patients: the ESPIA questionnaire,” Journal of Allergy and Clinical Immunology, vol. 131, no. 6, pp. 1539–1546.e2, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Valenta, “The future of antigen-specific immunotherapy of allergy,” Nature Reviews Immunology, vol. 2, pp. 446–453, 2002. View at Publisher · View at Google Scholar
  3. D. Toussi and P. Massari, “Immune adjuvant effect of molecularly-defined toll-like receptor ligands,” Vaccines, vol. 2, no. 2, pp. 323–353, 2014. View at Publisher · View at Google Scholar
  4. J. T. Ulrich and K. R. Myers, “Monophosphoryl lipid A as an adjuvant. Past experiences and new directions,” Pharmaceutical Biotechnology, vol. 6, pp. 495–524, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Kundi, “New hepatitis B vaccine formulated with an improved adjuvant system,” Expert Review of Vaccines, vol. 6, no. 2, pp. 133–140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. T. Agnandji, B. Lell, S. S. Soulanoudjingar et al., “First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children,” The New England Journal of Medicine, vol. 365, pp. 1863–1875, 2011. View at Publisher · View at Google Scholar
  7. B. Romanowski, P. C. de Borba, P. S. Naud et al., “Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years,” The Lancet, vol. 374, no. 9706, pp. 1975–1985, 2009. View at Publisher · View at Google Scholar
  8. P. Patel and A. M. F. Salapatek, “Pollinex® quattro: a novel and well-tolerated, ultra short-course allergy vaccine,” Expert Review of Vaccines, vol. 5, no. 5, pp. 617–629, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. R. Casella and T. C. Mitchell, “Putting endotoxin to work for us: monophosphoryl lipid a as a safe and effective vaccine adjuvant,” Cellular and Molecular Life Sciences, vol. 65, no. 20, pp. 3231–3240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Mothes, M. Heinzkill, K. J. Drachenberg et al., “Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: Reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies,” Clinical and Experimental Allergy, vol. 33, no. 9, pp. 1198–1208, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Baldrick, D. Richardson, G. Elliott, and A. W. Wheeler, “Safety evaluation of monophosphoryl lipid A (MPL): an immunostimulatory adjuvant,” Regulatory Toxicology and Pharmacology, vol. 35, no. 3, pp. 398–413, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Schülke, A. Flaczyk, L. Vogel et al., “MPLA shows attenuated pro-inflammatory properties and diminished capacity to activate mast cells in comparison with LPS,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 70, no. 10, pp. 1259–1268, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Schülke, M. Burggraf, Z. Waibler et al., “A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy,” Journal of Allergy and Clinical Immunology, vol. 128, no. 6, pp. 1340.e12–1348.e12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Tighe, K. Takabayashi, D. Schwartz et al., “Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity,” Journal of Allergy and Clinical Immunology, vol. 106, no. 1 I, pp. 124–134, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Kastenmüller, U. Wille-Reece, R. W. B. Lindsay et al., “Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets,” The Journal of Clinical Investigation, vol. 121, no. 5, pp. 1782–1796, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Filí, A. Vultaggio, E. Cardilicchia et al., “A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy,” Journal of Allergy and Clinical Immunology, vol. 132, no. 1, pp. 84–92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Schülke, Z. Waibler, M.-S. Mende et al., “Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DC,” Molecular Immunology, vol. 48, no. 1–3, pp. 341–350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. N. Domadia, A. Bhunia, A. Ramamoorthy, and S. Bhattacharjya, “Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization,” Journal of the American Chemical Society, vol. 132, no. 51, pp. 18417–18428, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Khan, M. S. Bijker, J. J. Weterings et al., “Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells,” The Journal of Biological Chemistry, vol. 282, no. 29, pp. 21145–21159, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Knoops and J.-C. Renauld, “IL-9 and its receptor: from signal transduction to tumorigenesis,” Growth Factors, vol. 22, no. 4, pp. 207–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Rampal, A. Awasthi, and V. Ahuja, “Retinoic acid-primed human dendritic cells inhibit Th9 cells and induce Th1/Th17 cell differentiation,” Journal of Leukocyte Biology, 2016. View at Publisher · View at Google Scholar
  23. G. Murugaiyan, V. Beynon, A. P. Da Cunha, N. Joller, and H. L. Weiner, “IFN-γ limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27,” The Journal of Immunology, vol. 189, no. 11, pp. 5277–5283, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. D. de Boer, J. J. T. H. Roelofs, A. F. de Vos et al., “Lipopolysaccharide inhibits Th2 lung inflammation induced by house dust mite allergens in mice,” American Journal of Respiratory Cell and Molecular Biology, vol. 48, no. 3, pp. 382–389, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Soudi, A. Zavaran-Hosseini, Z. M. Hassan, M. Soleimani, F. J. Adegani, and S. M. Hashemi, “Comparative study of the effect of LPS on the function of BALB/c and C57BL/6 peritoneal macrophages,” Cell Journal, vol. 15, no. 1, pp. 45–54, 2013. View at Google Scholar · View at Scopus
  26. F. Puggioni, S. R. Durham, and J. N. Francis, “Monophosphoryl lipid A (MPL®) promotes allergen-induced immune deviation in favour of Th1 responses,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 60, no. 5, pp. 678–684, 2005. View at Publisher · View at Google Scholar · View at Scopus